Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction

Heart

Volumn 88, Issue 2, 2002, Pages 125-130

  Schinkel, A F L ^a   Bax, J J ^b   Sozzi, F B ^a   Boersma, E ^a   Valkema, R ^a   Elhendy, A ^a   Roelandt, J R T C ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CELL VIABILITY; DATA ANALYSIS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0036076794     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.2.125     Document Type: Article

References (32)

1. Natural history and patterns of current practice in heart failure. The studies of left ventricular dysfunction (SOLVD) investigators
2. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function
3. Chronic heart failure in the United States - A manifestation of coronary artery disease
4. Trends in hospitalization rates for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
7. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
8. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction
9. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state
10. The hibernating myocardium
11. Hibernating myocardium
12. F18-fluorodesoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization
13. Identification of viable myocardium
14. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles
15. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy
16. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous, acquisition single-photon emission computed tomography
17. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera
18. Regional wall motion index for infarct and non-infarct region after reperfusion in acute myocardial infarction: Comparison with global wall motion index
19. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans
20. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction
21. Improvement of left ventricular ejectian fraction, heart failure symptoms and prognosis after revascularization in patients with chronic caronary artery disease and viable myocardium detected by dobutamine stress echocardiography
22. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism
23. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction
24. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
25. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
26. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
27. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
28. Comparison of sestamibi single-photon emission computed tomagraphy with positron emission tomography for estimating left ventricular myocardial viability
29. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: Comparison with fluorine-18-FDG PET
30. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria
31. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography
32. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18F-fluorodeoxyglucose